Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/24 19:21  | 6/21/24  | ATHA | Health | BioPrd | Biological Products, (No Diag | Romano Kelly A | WA | D | P.m | 100 | 2.36 | 0 | 42 | 111 | 81 | D | |||||||||||||||
12/29/23 17:24  | 12/27/23  | ATHA | Health | BioPrd | Biological Products, (No Diag | Perceptive Advisors LLC | NY | DT | P.m | 1,463 | 2.42 | 0 | 606 | 13 | 5,403 | I | |||||||||||||||
6/9/23 17:06  | 6/7/23  | ATHA | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | See Belo | P | 51 | 3.43 | 0 | 15 | 23 | 80 | D | ||||||||||||||
6/6/23 19:36  | 6/2/23  | ATHA | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | See Belo | P.m | 192 | 2.95 | 0 | 65 | New | 65 | D | ||||||||||||||
3/31/23 16:36  | 3/29/23  | ATHA | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | WA | D | P.m | 60 | 2.41 | 0 | 25 | 999% | 26 | D | |||||||||||||||
3/30/23 18:59  | 3/29/23  | ATHA | Health | BioPrd | Biological Products, (No Diag | Johnson James A | WA | D | P | 12 | 2.40 | 0 | 5 | New | 5 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |